Terry Roemer, PhD

Chairman, Founder & Chief Scientific Officer

Therapeutic Areas

Drug	Indication	Phase
Undisclosed Cell Envelope Program(s)	Infections by multidrug-resistant Gram-negative and Gram-positive bacteria	Pre-clinical